×
111 Change in Assets/Liabilities 2018-2025 | YI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
111 change in assets/liabilities from 2018 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
View More
111 Change in Assets/Liabilities 2018-2025 | YI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
111 change in assets/liabilities from 2018 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$44.5B
Doximity (DOCS)
$12.8B
Tempus AI (TEM)
$12.8B
Hims & Hers Health (HIMS)
$10B
IRhythm Technologies (IRTC)
$5.5B
Hinge Health (HNGE)
$4.5B
Inspire Medical Systems (INSP)
$2.7B
Privia Health (PRVA)
$2.7B
Heartflow (HTFL)
$2.6B
Phreesia (PHR)
$1.9B
10x Genomics (TXG)
$1.8B
Enovis (ENOV)
$1.7B
Omnicell (OMCL)
$1.5B
Schrodinger (SDGR)
$1.5B
Azenta (AZTA)
$1.4B
Clover Health Investments (CLOV)
$1.3B
Claritev (CTEV)
$1.2B
Evolent Health (EVH)
$1.1B
Fulgent Genetics (FLGT)
$674M
Zepp Health (ZEPP)
$550M
Veradigm (MDRX)
$534M
Standard BioTools (LAB)
$493M
Talkspace (TALK)
$445M
Butterfly Network (BFLY)
$410M
Carlsmed (CARL)
$363M
TruBridge (TBRG)
$300M
Health Catalyst (HCAT)
$257M
Outset Medical (OM)
$247M
SOPHiA GENETICS SA (SOPH)
$224M
Nyxoah SA (NYXH)
$214M